How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,145 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

8761. Clinical practice guideline: The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care

; the Health Economics Research Centre; Royal College of Nursing; and the UK Cochrane Centre. Disclaimer As with any clinical guideline, recommendations may not be appropriate for use in all circumstances. One limitation of a guideline is that it simplifies clinical decision-making (Shiffman 1997). Decisions to adopt any particular recommendations must be made by practitioners in the light of: ? available resources ? local services, policies and protocols ? the patient’s circumstances and wishes (...) BUP A 4 TH E U S E OF PR E S S U R E-R E L I EVI NG DEVICE S FO R TH E PR EVE NT ION OF PR E S S U R E U LCE RSChartered Society of Physiotherapists Clinical Interest Group in Orthotics, Prosthetics and Wheelchairs Cochrane W ounds Group College of Occupational Therapists Community Practitioners’ and Health Visitors’ Association Department of Health Frontier Therapeutics Ltd HMT Systems Judy Mead Kaymed Medical Support Systems Ltd National Association of Tissue Viability Nurses Southern Group

2007 Royal College of Nursing

8762. Guidance for mentors of student nurses and midwives. An RCN toolkit

23 9. Glossary of terms 25 10. References, recommended reading and useful websites 262 GU IDA NCE FO R M E NTO RS Foreword Your role as a mentor is critical in helping to facilitate the development of future generations of nurses and midwives. As a mentor you have the privilege and responsibility of helping students translate theory into practice, and making what is learned in the classroom a reality. It is a role that you are entrusted with by students, colleagues and most importantly, patients (...) for at least one year before taking on this role. 4 GU IDA NCE FO R M E NTO RS ROYA L C OLL E G E OF N U RS I N G 5 2 The role of mentor As a mentor you are required to offer the student support and guidance in the practice area. Your role is to enable the student to make sense of their practice through: ? the application of theory ? assessing, evaluating and giving constructive feedback ? facilitating reflection on practice, performance and experiences. All mentors, and others involved in supporting

2005 Royal College of Nursing

8763. Maternal depression and child development

and of safety of breast-feeding. J Psychopharmacol 1999;13:64-80. Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000;343:118-26. Yoshida K, Smith B, Craggs M, Channi Kumar R. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998;172:175-9. Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001;158:1001-9. Yoshida K, Smith B, Craggs M, Kumar RC. Investigation (...) in pregnancy should be continued in the postnatal period. The infant’s exposure to SSRIs can be reduced by emptying the breasts of milk and discarding it (‘pump and dump’) approximately 8 h to 9 h after the mother has taken the medication . Although there is no final consensus on the use of antidepressants during pregnancy and lactation, antidepressant therapy should be considered in the context of a comprehensive risk-benefit assessment, as illustrated by the decision model of Wisner et al

2004 Canadian Paediatric Society

8764. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty

Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty Bozic K J, Morshed S, Silverstein M D, Rubash H E, Kahn (...) Supported by the Orthapedic Research and Education Foundation. Bibliographic details Bozic K J, Morshed S, Silverstein M D, Rubash H E, Kahn J G. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty. Journal of Bone and Joint Surgery 2006; 88(4): 706-714 PubMedID DOI Other publications of related interest Vale L, Wyness L, McCormack K, et al. A systematic review of the effectiveness and cost-effectiveness

Full Text available with Trip Pro

2006 NHS Economic Evaluation Database.

8765. When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care

Supported by a grant from West Midlands Regional Health Authority. Bibliographic details Boath E, Major K, Cox J. When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care. Journal of Affective Disorders 2003; 74(2): 159-166 PubMedID Other publications of related interest Boath E, Cox J, Lewis M, et al. When the cradle falls: the treatment of postnatal depression in a psychiatric day hospital compared with routine (...) When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care Boath E, Major K, Cox J Record Status This is a critical

2003 NHS Economic Evaluation Database.

8766. A cost-effectiveness analysis of a hypothetical catheter-based strategy for the detection and treatment of vulnerable coronary plaques with drug-eluting stents

M T, Muller J E, Brady T, Gazelle G S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of a catheter-based strategy for the detection and subsequent treatment of vulnerable coronary plaques in patients with coronary (...) treatment options for vulnerable plaques should be evaluated in future studies. Source of funding Partly supported by the US Department of the Army. Bibliographic details Bosch J L, Beinfeld M T, Muller J E, Brady T, Gazelle G S. A cost-effectiveness analysis of a hypothetical catheter-based strategy for the detection and treatment of vulnerable coronary plaques with drug-eluting stents. Journal of Interventional Cardiology 2005; 18(5): 339-349 PubMedID DOI Other publications of related interest Muller

2005 NHS Economic Evaluation Database.

8767. Alcohol interventions for trauma patients treated in emergency departments and hospitals: a cost benefit analysis

Alcohol interventions for trauma patients treated in emergency departments and hospitals: a cost benefit analysis Alcohol interventions for trauma patients treated in emergency departments and hospitals: a cost benefit analysis Alcohol interventions for trauma patients treated in emergency departments and hospitals: a cost benefit analysis Gentilello L M, Ebel B E, Wickizer T M, Salkever D S, Rivara F P Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) of the retrieved studies, making it difficult to comment on the quality of the efficacy estimates. However, the authors carried out several sensitivity analyses relating to the efficacy estimates. These analyses improve both the internal validity and the generalisability of the study by demonstrating the robustness of the results to changes in the base-case estimates. The estimates of effectiveness that were based on authors' assumptions were provided with reference to the medical literature. Validity

2005 NHS Economic Evaluation Database.

8768. Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms

Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms Grau S, Mateu de Antonio J, Soto J, Marin Casino M, Salas E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED (...) -line treatment. Implications of the study The study results supported the use of linezolid for the treatment of bacteraemia caused by Gram-positive micro-organisms. Source of funding None stated. Bibliographic details Grau S, Mateu de Antonio J, Soto J, Marin Casino M, Salas E. Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms. Pharmacy World and Science 2005; 27(6): 459-464 PubMedID DOI Other publications of related interest Because readers

2005 NHS Economic Evaluation Database.

8769. Telemedicine network telecolposcopy compared with computer-based telecolposcopy

is the least cost strategy to evaluate cervical abnormalities in rural women? Comparing telemedicine, local practitioners, and expert physicians." Medical Decision Making 2003;23:463-70. Indexing Status Subject indexing assigned by NLM AccessionNumber 22004008868 Date bibliographic record published 31/01/2006 Date abstract record published 31/01/2006 NHS Economic Evaluation Database (NHS EED) Produced by the Centre for Reviews and Dissemination Copyright © 2019 University of York Homepage Options Print (...) Telemedicine network telecolposcopy compared with computer-based telecolposcopy Telemedicine network telecolposcopy compared with computer-based telecolposcopy Telemedicine network telecolposcopy compared with computer-based telecolposcopy Ferris D G, Bishai D M, Litaker M S, Dickman E D, Miller J A, Macfee M S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results

2004 NHS Economic Evaluation Database.

8770. Cost-effectiveness of screening strategies for gonorrhea among females in private sector care

Cost-effectiveness of screening strategies for gonorrhea among females in private sector care Cost-effectiveness of screening strategies for gonorrhea among females in private sector care Cost-effectiveness of screening strategies for gonorrhea among females in private sector care Bernstein K T, Mehta S D, Rompalo A M, Erbelding E J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) old, or those who reported any risk. These screening strategies were compared with a background no-screening option. Location/setting USA/private medical clinic. Methods Analytical approach: This economic evaluation was based on a decision analytic model which compared the six screening strategies with no screening. The time horizon was 10 years and the authors did not report their perspective. Effectiveness data: The clinical data were derived from a selection of known, relevant studies

Full Text available with Trip Pro

2006 NHS Economic Evaluation Database.

8771. Cost-effectiveness of whole-body CT screening

Cost-effectiveness of whole-body CT screening Cost-effectiveness of whole-body CT screening Cost-effectiveness of whole-body CT screening Beinfeld M T, Wittenberg E, Gazelle G S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology (...) , owing to the low prevalence of disease. The authors stated that future studies should investigate the impact of race, income and education on the costs and benefits of screening. Source of funding Supported in part by a grant from the American College of Radiology. Bibliographic details Beinfeld M T, Wittenberg E, Gazelle G S. Cost-effectiveness of whole-body CT screening. Radiology 2005; 234(2): 415-422 PubMedID DOI Other publications of related interest Mahadevia PJ, Fleisher LA, Frick KD, et al

2005 NHS Economic Evaluation Database.

8772. Use of frozen semen to avoid human immunodeficiency virus type 1 transmission by donor insemination: a cost-effectiveness analysis

Use of frozen semen to avoid human immunodeficiency virus type 1 transmission by donor insemination: a cost-effectiveness analysis Use of frozen semen to avoid human immunodeficiency virus type 1 transmission by donor insemination: a cost-effectiveness analysis Use of frozen semen to avoid human immunodeficiency virus type 1 transmission by donor insemination: a cost-effectiveness analysis Payne M A, Lamb E J Record Status This is a critical abstract of an economic evaluation that meets (...) evaluation were insemination with fresh or frozen semen, lifetime medical care, lifetime HIV treatment for a child, litigation for one HIV infection, and pregnancy loss treatment. The cost/resource boundary of the study was unclear. The resource use data came from the review of the literature, from which the probability values used in the decision model were derived. The costs were mainly estimated from studies published between 1995 and 1998, and were then presented in 2000 values. Statistical analysis

2004 NHS Economic Evaluation Database.

8773. The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles

The effectiveness evidence was derived from a synthesis of published studies. Modelling A decision tree was constructed to assess the costs and benefits of the three strategies examined in the study. Limited information on the characteristics of the tree was reported. The time horizon of the model appears to have been lifetime. The authors stated that the model took the hypothesis that infection acquired during pregnancy is associated with the same risk of congenital varicella syndrome (CVS) or neonatal disease (...) benefit measure used was the expected number of cases of varicella in pregnancy. This was estimated from the decision model. Other model outputs were also reported. These included varicella cases, varicella-related deaths, children born with CVS, and neonatal varicella cases. The benefits were discounted at an annual rate of 3.5%. Direct costs The analysis of the costs was carried out from the perspective of the NHS. It included the costs of general practitioner (GP) consultations, nurse consultations

2006 NHS Economic Evaluation Database.

8774. Cost-effectiveness of PET in the diagnosis of Alzheimer disease

disease. Neurology 1999;52:1138-45. McMahon P, Araki S, Neumann P, Harris G, Gazelle G. Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease. Radiology 2000;217:58-68. Neumann P, Sandberg E, Araki S, et al. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease. Medical Decision Making 2000;20:413-22. Indexing Status Subject indexing assigned by NLM MeSH Alzheimer Disease /diagnosis /radionuclide imaging; Cost-Benefit Analysis; Decision Trees; Health Care (...) Cost-effectiveness of PET in the diagnosis of Alzheimer disease Cost-effectiveness of PET in the diagnosis of Alzheimer disease Cost-effectiveness of PET in the diagnosis of Alzheimer disease McMahon P M, Araki S S, Sandberg E A, Neumann P J, Gazelle G S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment

2003 NHS Economic Evaluation Database.

8775. Cost perspectives of laparoscopic and open appendectomy

Cost perspectives of laparoscopic and open appendectomy Cost perspectives of laparoscopic and open appendectomy Cost perspectives of laparoscopic and open appendectomy Moore D E, Speroff T, Grogan E, Poulose B, Holzman M D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) . Implications of the study Although from the hospital perspective open appendectomy appears to be the optimal strategy, laparoscopic appendectomy seems to be optimal from the societal perspective. Decision analyses can help in the understanding of a wide range of clinical scenarios and patient characteristics, and can help detect contributing factors in the determination of the optimal strategy for appendectomy. Source of funding None stated. Bibliographic details Moore D E, Speroff T, Grogan E, Poulose B

2005 NHS Economic Evaluation Database.

8776. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Dubinsky M C, Reyes E, Ofman J, Chiou (...) Dubinsky M C, Reyes E, Ofman J, Chiou C F, Wade S, Sandborn W J. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. American Journal of Gastroenterology 2005; 100(10): 2239-2247 PubMedID DOI Indexing Status Subject indexing assigned by NLM MeSH 6-Mercaptopurine /administration & Azathioprine /administration & Community Health Services /economics; Cost-Benefit Analysis; Crohn Disease /drug therapy

2005 NHS Economic Evaluation Database.

8777. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity

The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity Armstrong G L, Billah K, Rein D B, Hicks K A, Wirth K E, Bell B P Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) in the previous model but further detail will be found in Rein et al 2007. The clinical data used in the current model were the effects of herd immunity, the estimated proportion of infections prevented by herd immunity, and the proportion of hepatitis A infection acquired abroad by US adults. Modelling A published decision model was used to simulate the natural history of disease (no vaccination) and the subsequent impact of vaccination in the first 10 birth cohorts starting in 2005 and ending in 2014

2007 NHS Economic Evaluation Database.

8778. Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder

E P, Skrepnek G H, Erder M H. Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. Current Medical Research and Opinion 2007; 23(2): 251-258 PubMedID DOI Other publications of related interest Because readers are likely to encounter and assess individual publications, NHS EED abstracts reflect the original publication as it is written, as a stand-alone paper. Where NHS EED abstractors are able to identify positively that a publication (...) Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder Armstrong E P, Skrepnek G H, Erder M H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary

2007 NHS Economic Evaluation Database.

8779. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis

: a cost-utility analysis. American Journal of Gastroenterology 2003; 98(3): 679-690 PubMedID Other publications of related interest Colombo M. Screening for cancer in viral hepatitis. Clinics in Liver Disease 2001;5:109-22. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. American Journal of Medicine 1996;101:422-34 Indexing Status Subject indexing assigned by NLM MeSH Aged (...) Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis Arguedas M R, Chen V K, Eloubeidi M A, Fallon M B Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains

2003 NHS Economic Evaluation Database.

8780. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach

Ament A J, Hubben M W, Verweij P E, de Groot R, Warris A, Donnelly J P, van 't Wout J, Severens J L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study modelled the cost-effectiveness of targeted antifungal treatment strategies (...) remarks: The methodology of the study appears to have been appropriate and, on the whole, was clearly and transparently reported. The conclusions appear to be appropriate. Funding Supported by UCB Pharma BV and Gilead Sciences. Bibliographic details Ament A J, Hubben M W, Verweij P E, de Groot R, Warris A, Donnelly J P, van 't Wout J, Severens J L. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands

Full Text available with Trip Pro

2007 NHS Economic Evaluation Database.

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>